[1]Patent:US2002/65418,2002,A1
[1]ACSInfectiousDiseases,2019,vol.5,p.2014-2028
50919-08-9
100570-24-9
101589-21-3
121734-64-3
62409-13-6
854184-18-2
1255718-32-1 | 1-(1-Piperidinyl)cyclohexanecarboxylic acid hydrochloride | AA00J3E7 | MFCD13186351
1609407-62-6 | N-(2,6-difluorobenzyl)-1-methoxy-2-propanamine hydrobromide | AA00J3HK | MFCD13186292
1609409-00-8 | N-(3-Nitrobenzyl)cyclopentanamine hydrobromide | AA00J3KE | MFCD13186509
1609408-89-0 | (2-methoxyethyl)[2-(2-naphthyloxy)ethyl]amine hydrochloride | AA00J3NA | MFCD13186537
944467-99-6 | Ethyl 4-(aminomethyl)-2,5-dimethyl-3-furoate hydrochloride | AA00J3QG | MFCD02815369
1051364-44-3 | [(5-Methyl-2-thienyl)methyl](4-pyridinylmethyl)amine hydrochloride | AA00J3TO | MFCD07109048
1049678-14-9 | N-(4-pyridinylmethyl)-2-butanamine hydrochloride | AA00J3WQ | MFCD07107491
1159700-18-1 | (2E)-N-(2-methoxyethyl)-3-phenyl-2-propen-1-amine hydrochloride | AA00J3ZT | MFCD07111217
1239130-22-3 | 3-methyl-4-(3-methylphenyl)-1H-pyrazol-5-amine | AA00J5ZG | MFCD12027287
1020955-36-5 | 3-thien-3-ylisoxazol-5-amine | AA00J8BP | MFCD11156304